National Research Corporation (NRC)
NASDAQ · Healthcare
National Research Corporation Shareholder Equity 2009–2025
National Research Corporation annual shareholder equity history from 2010 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- National Research Corporation shareholder equity as of December 31, 2025: 14.0M, a 55.28% decrease year-over-year.
- National Research Corporation shareholder equity for 2025 were 14.0M, a 55.28% decrease from 2024.
- National Research Corporation shareholder equity for 2024 were 31.3M, a 36.10% decrease from 2023.
- National Research Corporation shareholder equity for 2023 were 49.0M, a 32.04% decrease from 2022.
- National Research Corporation shareholder equity for 2022 were 72.0M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| National Research Corporation Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $14 |
| 2024 | $31 |
| 2023 | $49 |
| 2022 | $72 |
| 2021 | $85 |
| 2020 | $64 |
| 2019 | $33 |
| 2018 | $19 |
| 2017 | $90 |
| 2016 | $83 |
| 2015 | $74 |
| 2014 | $88 |
| 2013 | $72 |
| 2012 | $57 |
| 2011 | $56 |
National Research Corporation Shareholder Equity — FAQ
National Research Corporation (NRC) shareholder equity over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see NRC's shareholder equity history?
The chart and table above show National Research Corporation's shareholder equity by year and by quarter, including the growth rate.